Invega® (paliperidone) is a medication that is taken to help improve the symptoms of schizophrenia and schizoaffective disorder. It belongs to a group of drugs called atypical (or second-generation) antipsychotics and is believed to work by blocking or lessening the effects of certain chemicals in the brain.
In previous clinical studies, people taking Invega experienced improvements in their schizophrenia symptoms (including hallucinations and suspiciousness), compared to those not taking it. Longer studies also showed that Invega can help prevent hospitalization due to schizophrenia and can help symptoms from returning.
Invega comes in tablet form and is usually taken once a day in the morning. The tablets are specially designed to slowly release the medication over time. They should be swallowed whole with water (or other liquids) and should not be crushed, chewed, or broken. A long-acting injectable form (Invega Sustenna™) is also available.
(Click Invega for more information on when and how to take the oral tablets, to learn about Invega's potential side effects, and to find out what you should discuss with your healthcare provider before starting treatment.)
Written by/reviewed by: Kristi Monson, PharmD;Arthur Schoenstadt, MD
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: Approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed April 30, 2007.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click